BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 12051111)

  • 21. Endometrial blood flow response to estrogen replacement therapy and tamoxifen in asymptomatic, postmenopausal women: a transvaginal Doppler study.
    Achiron R; Lipitz S; Frenkel Y; Mashiach S
    Ultrasound Obstet Gynecol; 1995 Jun; 5(6):411-4. PubMed ID: 7552804
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial thickness and Doppler velocimetry of the uterine arteries as discriminators of endometrial status in women with postmenopausal bleeding: a comparative study.
    Sladkevicius P; Valentin L; Marsál K
    Am J Obstet Gynecol; 1994 Sep; 171(3):722-8. PubMed ID: 8092221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Short-term treatment with levonorgestrel does not antagonize the ethinyl estradiol-induced increase of uterine blood flow in postmenopausal women.
    Entezami M; Heger-Mahn D; Ebert A; Halis G; Lübbert H
    Contraception; 1997 Sep; 56(3):181-3. PubMed ID: 9347210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum placental protein 14: a novel marker of selective oestrogen receptor modulator action on the postmenopausal endometrium.
    Tankó LB; Warming L; Bagger YZ; Byrjalsen I; Jensen S; Christiansen C
    Biomarkers; 2002; 7(3):257-66. PubMed ID: 12141068
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Conjugated equine estrogen, raloxifene and arterial stiffness in postmenopausal women.
    Dias AR; de Mello NR; Eluf Gebara OC; Nussbacher A; Wajngarten M; Petti DA
    Climacteric; 2008 Oct; 11(5):390-6. PubMed ID: 18781483
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Endometrial and myometrial thickness and uterine blood flow in postmenopausal women: the influence of hormonal replacement therapy and age.
    Zalud I; Conway C; Schulman H; Trinca D
    J Ultrasound Med; 1993 Dec; 12(12):737-41. PubMed ID: 8301713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Randomized control study of the effects of raloxifene on serum lipids and homocysteine in older women.
    De Leo V; la Marca A; Morgante G; Lanzetta D; Setacci C; Petraglia F
    Am J Obstet Gynecol; 2001 Feb; 184(3):350-3. PubMed ID: 11228485
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of raloxifene on carotid blood flow resistance and endothelium-dependent vasodilation in postmenopausal women.
    Ceresini G; Marchini L; Rebecchi I; Morganti S; Bertone L; Montanari I; Bacchi-Modena A; Sgarabotto M; Baldini M; Denti L; Ablondi F; Ceda GP; Valenti G
    Atherosclerosis; 2003 Mar; 167(1):121-7. PubMed ID: 12618276
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uterine effects of raloxifene in comparison with continuous-combined hormone replacement therapy in postmenopausal women.
    Fugère P; Scheele WH; Shah A; Strack TR; Glant MD; Jolly E
    Am J Obstet Gynecol; 2000 Mar; 182(3):568-74. PubMed ID: 10739509
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Assessment of uterine artery and arcuate artery blood flow by transvaginal color Doppler ultrasound on the day of human chorionic gonadotropin administration as predictors of pregnancy in an in vitro fertilization program.
    Ivanovski M; Damcevski N; Radevska B; Doicev G
    Akush Ginekol (Sofiia); 2012; 51(2):55-60. PubMed ID: 23234017
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reproducibility of transvaginal Doppler velocimetry measurements in the uterine arteries of postmenopausal women.
    Tekay A; Järvelä I; Jouppila P
    Ultrasound Obstet Gynecol; 1997 Sep; 10(3):198-204. PubMed ID: 9339527
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Transvaginal Doppler examination of uteri with myomas.
    Sladkevicius P; Valentin L; Marsál K
    J Clin Ultrasound; 1996; 24(3):135-40. PubMed ID: 8838302
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Normal uterine arterial blood flow in postmenopausal women assessed by transvaginal color Doppler sonography: the effect of hormone replacement therapy.
    Bonilla-Musoles F; Martí MC; Ballester MJ; Raga F; Osborne NG
    J Ultrasound Med; 1995 Jul; 14(7):497-501. PubMed ID: 7563296
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Uterine perfusion and endometrial thickness in postmenopausal women on long-term continuous combined estrogen and progestogen replacement.
    Dören M; Süselbeck B; Schneider HP; Holzgreve W
    Ultrasound Obstet Gynecol; 1997 Feb; 9(2):113-9. PubMed ID: 9132253
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endometrial blood flow analysis in postmenopausal women: can it help differentiate benign from malignant causes of endometrial thickening?
    Sheth S; Hamper UM; McCollum ME; Caskey CI; Rosenshein NB; Kurman RJ
    Radiology; 1995 Jun; 195(3):661-5. PubMed ID: 7753990
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years.
    Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW
    Menopause; 2003; 10(4):337-44. PubMed ID: 12851517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endometrial blood flow mapping using transvaginal power Doppler sonography in women with postmenopausal bleeding and thickened endometrium.
    Alcázar JL; Castillo G; Mínguez JA; Galán MJ
    Ultrasound Obstet Gynecol; 2003 Jun; 21(6):583-8. PubMed ID: 12808676
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Clinical value of the measurement of blood flow in uterine arteries and endometrial vessels in women with postmenopausal bleeding using "power" angio Doppler technique].
    Englert-Golon M; Szpurek D; Moszyński R; Pawlak M; Sajdak S
    Ginekol Pol; 2006 Oct; 77(10):759-63. PubMed ID: 17219807
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Uterine and cerebral vascularization in postmenopausal women treated with hormone-replacement therapy.
    Battaglia C; Regnani G; Artini PG; Genazzani AR; Primavera MR; Salvatori M; Volpe A
    Gynecol Endocrinol; 1999 Aug; 13(4):223-9. PubMed ID: 10533156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Veralipride administered in combination with raloxifene decreases hot flushes and improves bone density in early postmenopausal women.
    Morgante G; Farina M; Cianci A; La Marca A; Petraglia F; De Leo V
    Gynecol Endocrinol; 2004 Apr; 18(4):194-8. PubMed ID: 15293890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.